Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV

Research output: Contribution to journalJournal articleResearchpeer-review

  • Alexey Stukalov
  • Virginie Girault
  • Vincent Grass
  • Ozge Karayel
  • Valter Bergant
  • Christian Urban
  • Darya A Haas
  • Yiqi Huang
  • Lila Oubraham
  • Anqi Wang
  • M Sabri Hamad
  • Antonio Piras
  • Fynn M Hansen
  • Maria C Tanzer
  • Igor Paron
  • Luca Zinzula
  • Thomas Engleitner
  • Maria Reinecke
  • Teresa M Lavacca
  • Rosina Ehmann
  • Roman Wölfel
  • Jörg Jores
  • Bernhard Kuster
  • Ulrike Protzer
  • Roland Rad
  • John Ziebuhr
  • Volker Thiel
  • Pietro Scaturro
  • Andreas Pichlmair

The emergence and global spread of SARS-CoV-2 has resulted in the urgent need for an in-depth understanding of molecular functions of viral proteins and their interactions with the host proteome. Several individual omics studies have extended our knowledge of COVID-19 pathophysiology1-10. Integration of such datasets to obtain a holistic view of virus-host interactions and to define the pathogenic properties of SARS-CoV-2 is limited by the heterogeneity of the experimental systems. Here we report a concurrent multi-omics study of SARS-CoV-2 and SARS-CoV. Using state-of-the-art proteomics, we profiled the interactomes of both viruses, as well as their influence on the transcriptome, proteome, ubiquitinome and phosphoproteome of a lung-derived human cell line. Projecting these data onto the global network of cellular interactions revealed crosstalk between the perturbations taking place upon infection with SARS-CoV-2 and SARS-CoV at different levels and enabled identification of distinct and common molecular mechanisms of these closely related coronaviruses. The TGF-β pathway, known for its involvement in tissue fibrosis, was specifically dysregulated by SARS-CoV-2 ORF8 and autophagy was specifically dysregulated by SARS-CoV-2 ORF3. The extensive dataset (available at https://covinet.innatelab.org ) highlights many hotspots that could be targeted by existing drugs and may be used to guide rational design of virus- and host-directed therapies, which we exemplify by identifying inhibitors of kinases and matrix metalloproteases with potent antiviral effects against SARS-CoV-2.

Original languageEnglish
JournalNature
ISSN0028-0836
DOIs
Publication statusE-pub ahead of print - 12 Apr 2021
Externally publishedYes

ID: 261519914